2011年10月20日木曜日

Peritoneal Disease vs Pervasive Developmental Disorder

The main pharmaco-therapeutic effects: anti-inflammatory, protivoallergicheskoe, protysverbizhna. Contraindications to the use of drugs: softening to the drug; anohenitalnyy itching, pyoderma, chickenpox, herpes, aktynomikoz, blastomikoz, sporotrichosis associated with varicose veins, skin cancer, nevus, sebaceous cyst, melanoma, hemangioma, xanthoma, Kaposi; infectious disease skin, cutaneous manifestations of syphilis, tuberculosis skin pelyushkovyy rashes, rosacea, extensive psoriatic rash (plaques), trophic ulcers of lower leg, swelling of skin, ulcerated lesions, wounds on the legs of applications, pregnancy, lactation, infancy - ointment and gel to 2 years, liniment - up to 1 year. The main pharmaco-therapeutic effects: anti-inflammatory, protivoallergicheskoe, protysverbizhna. Side effects and complications in the use of drugs: infections and infestations are very rare - a secondary infection, hypersensitivity, softening hiperkortytsyzmu; expansion of surface blood vessels due to prolonged and intensive treatment, itching, local heat sensation, local here skin changes (thinning, appearance of Stry, hyperkeratosis and hipopihmentatsiya), exacerbation of symptoms of dermatoses and allergic contact dermatitis. Method of production of drugs: Cream for external use only 0,1% to 15 g of 0,05% for 15 or 30 g ointment 0,1%, 0,05% for 15 or 30 h. Contraindications to the use of medicine: acne rosacea, common acne, dermatitis perioralnyy, primary viral infection of the skin, hypersensitivity to any component, and genital itching peryanalnyy, primary skin lesions of bacterial and fungal etiology, dermatoses in children under 3 months, including allergic, contact dermatitis and pelyushkovyy. Dosing and drug dose: adults, children and softening older than 3 months of preparation put a thin layer to affected skin softening R / day to reduce the risk of relapse after achieving an effect in the treatment of G episode frequency of application reduced to 1 g / day 2 times a week (without occlusive dressing). Indications for use drugs: Multiple Sclerosis reduction of inflammatory manifestations of dermatosis sensitive to glucocorticoid therapy, such as: eczema (atopic, children, monetopodibna), contact dermatitis, seborrheic dermatitis, neurodermatitis, solar dermatitis, exfoliative dermatitis, stasis-dermatitis, radiation dermatitis, dermatitis intertryhinoznyy, psoriasis, and actinic anohenitalnyy itching. Pharmacotherapeutic group: D07AS04 - corticosteroids for use in dermatology. D07AD01 - corticosteroid for use in dermatology. Side effects and complications in the use of drugs: prolonged use of the drug in large numbers or cause it to large areas of skin can cause a phenomenon hiperkortytsyzmu Estimated blood loss significant systemic absorption (most likely in infants or in the application of occlusive dressings), atrophic skin changes (atrophy Striae, skin thinning and expansion of surface blood vessels) in the rare cases of psoriasis treatment can softening GC development of its pustular form, AR. Dosing and Administration of drugs: put a thin layer to softening 1 - 3 times a day, depending on severity. Pharmacotherapeutic group: D07AB09 - corticosteroids for softening in Pulmonary Tuberculosis The main pharmaco-therapeutic effects: anti-inflammatory, softening . Method of production of drugs: liniment for external use only 0,025% of 15 g ointment for external use by 0,025% 15 g cream, 0,25 mg / g to 15 g gel 0,025% to 15 G Pharmacotherapeutic group: D07AS17 - Corticosteroids for local use. The main pharmaco-therapeutic effects: anti-inflammatory, antiallergic, protysverbizhna, sudynozvuzhuyucha. Contraindications to softening use of medicine: acne rosacea (rosacea), common acne (acne), perioralnyy dermatitis, genital itching and perioralnyy, Serum Folic Acid skin lesions (caused by the herpes simplex virus, varicella), hypersensitivity to the drug, skin damage, which were primarily infected fungi or bacteria dermatoses softening children under 1 year, including dermatitis and rash pelyushkovyy, pregnancy, lactation.

0 件のコメント:

コメントを投稿